Tavanta’s Respiratory franchise is focused on developing peptide-based drugs for inhalation. Our initial focus is cystic fibrosis.

Overview of Cystic Fibrosis
Current Treatments and Unmet Needs

1 Guo J, Garratt A, Hill A. Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros. 2022 May;21(3):456-462.

2 Almughem FA, Aldossary AM, Tawfik EA, et al. Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies. Pharmaceutics. 2020 Jul 2;12(7):616.

3 Cystic Fibrosis Foundation Drug Development Pipeline: https://apps.cff.org/trials/pipeline/

4 Allen L, Allen L, Carr SB, et al. Future therapies for cystic fibrosis. Nat Commun. 2023 Feb 8;14(1):693.